药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Podofilox
Melperone
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Melperone.
Podofilox
Butriptyline
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Butriptyline.
Podofilox
Eperisone
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Eperisone.
Podofilox
Fendiline
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Fendiline.
Podofilox
Bedaquiline
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Bedaquiline.
Podofilox
Antazoline
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Antazoline.
Podofilox
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Nemonoxacin.
Podofilox
Telavancin
The risk or severity of QTc prolongation can be increased when Telavancin is combined with Pazopanib.
Podofilox
Tucidinostat
The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Pazopanib.
Podofilox
Tedisamil
The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Pazopanib.
Podofilox
Garenoxacin
The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Pazopanib.
Podofilox
Pracinostat
The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Pazopanib.
Podofilox
Azimilide
The risk or severity of QTc prolongation can be increased when Azimilide is combined with Pazopanib.
Podofilox
Fluspirilene
The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Pazopanib.
Podofilox
Prenylamine
The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Pazopanib.
Podofilox
Terlipressin
The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Pazopanib.
Podofilox
Aceprometazine
The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Pazopanib.
Podofilox
Probucol
The risk or severity of QTc prolongation can be increased when Probucol is combined with Pazopanib.
Podofilox
Terodiline
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Terodiline.
Podofilox
Macimorelin
The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Macimorelin.